Department of Pulmonary and Critical Care Medicine, Naval Medical Center Portsmouth, Portsmouth, VA.
Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC.
J Cardiothorac Vasc Anesth. 2022 Sep;36(9):3570-3575. doi: 10.1053/j.jvca.2022.04.007. Epub 2022 Apr 14.
To compare screening scores for heparin-induced thrombocytopenia (HIT) after cardiopulmonary bypass (CPB).
Retrospective cohort study.
Cardiothoracic surgery units within a large tertiary healthcare facility from September 2010 to January 2020.
All adult patients tested for heparin-induced platelet antibody (HIPA) within 2 weeks after surgery requiring CPB.
Using data available to providers at the time HIPA were checked, the 4T's Score, a modified 4T's Score, and a score proposed by Lillo-Le Louet (LLL) et al. were calculated. A retrospective chart review was performed for each patient to determine actual presence of HIT, and screening scores were compared for accuracy.
Criteria for inclusion were met in 266 patients. Of these, 34 (12.8%) were high likelihood of HIT, 16 (6.0%), additional patients were clinically ambiguous, and 216 (81.2%) were high likelihood of alternative cause for thrombocytopenia. HIPA tests done before postoperative day 5 were not associated with any high-likelihood cases of HIT regardless of preoperative heparin exposure. Although traditional 4T's ≥4, modified 4T's ≥3, and LLL ≥2 had statistically similar sensitivity for predicting HIT, the modified 4T's and LLL had superior specificity (p < 0.001).
Appropriate screening for HIT curbed inappropriate HIPA testing, and reduced the need for empirical treatment while awaiting confirmatory test results. Traditional 4T's was statistically inferior to both the LLL score and a modified version of the 4T's to screen for HIT within 2 weeks of CPB.
比较体外循环(CPB)后肝素诱导的血小板减少症(HIT)的筛查评分。
回顾性队列研究。
2010 年 9 月至 2020 年 1 月期间,在一家大型三级保健设施的心胸外科病房内。
所有在手术后 2 周内接受 CPB 并检测肝素诱导血小板抗体(HIPA)的成年患者。
使用在检查 HIPA 时提供给医务人员的数据,计算 4T's 评分、改良的 4T's 评分和 Lillo-Le Louet(LLL)等人提出的评分。对每位患者进行回顾性病历审查以确定实际存在 HIT,并比较筛查评分的准确性。
符合纳入标准的患者为 266 例。其中,34 例(12.8%)有高度疑似 HIT,16 例(6.0%)为临床不确定病例,216 例(81.2%)有血小板减少症的其他可能原因。无论术前是否使用肝素,术后第 5 天之前进行的 HIPA 检测均与任何高度疑似 HIT 无关。尽管传统的 4T's≥4、改良的 4T's≥3 和 LLL≥2 对预测 HIT 的敏感性统计学上相似,但改良的 4T's 和 LLL 的特异性更高(p<0.001)。
适当的 HIT 筛查可以减少不必要的 HIPA 检测,并在等待确认性检测结果的同时减少经验性治疗的需要。与 LLL 评分和改良的 4T's 评分相比,传统的 4T's 在 CPB 后 2 周内筛查 HIT 的统计学性能较差。